Enhanced tumor accumulation and therapeutic efficacy of liposomal drugs through over-threshold dosing

Abstract

Background Most intravenously administered drug-loaded nanoparticles are taken up by liver Kupffer cells, and only a small portion can accumulate at the tumor, resulting in an unsatisfactory therapeutic efficacy and side effects for chemotherapeutic agents. Tumor-targeted drug delivery proves to be the best way to solve this problem; however, the complex synthesis, or surface modification process, together with the astonishing high cost make its clinical translation nearly impossible. Methods Referring to Ouyang’s work and over-threshold dosing theory in general, blank PEGylated liposomes (PEG-Lipo) were prepared and used as tumor delivery enhancers to determine whether they could significantly enhance the tumor accumulation and in vivo antitumor efficacy of co-injected liposomal ACGs (PEG-ACGs-Lipo), a naturally resourced chemotherapeutic. Here, the phospholipid dose was used as an indicator of the number of liposomes particles with similar particle sizes, and the liposomes was labelled with DiR, a near-red fluorescent probe, to trace their in vivo biodistribution. Two mouse models, 4T1-bearing and U87-bearing, were employed for in vivo examination. Results PEG-Lipo and PEG-ACGs-Lipo had similar diameters. At a low-threshold dose (12 mg/kg equivalent phospholipids), PEG-Lipo was mainly distributed in the liver rather than in the tumor, with the relative tumor targeting index (RTTI) being ~ 0.38 at 72 h after administration. When over-threshold was administered (50 mg/kg or 80 mg/kg of equivalent phospholipids), a much higher and quicker drug accumulation in tumors and a much lower drug accumulation in the liver were observed, with the RTTI increasing to ~ 0.9. The in vivo antitumor study in 4T1 tumor-bearing mice showed that, compared to PEG-ACGs-Lipo alone (2.25 mg/kg phospholipids), the co-injection of a large dose of blank PEG-Lipo (50 mg/kg of phospholipids) significantly reduced the tumor volume of the mice by 22.6% (P < 0.05) and enhanced the RTTI from 0.41 to 1.34. The intravenous injection of a low drug loading content (LDLC) of liposomal ACGs (the same dose of ACGs at 50 mg/kg of equivalent phospholipids) achieved a similar tumor inhibition rate (TIR) to that of co-injection. In the U87 MG tumor-bearing mouse model, co-injection of the enhancer also significantly promoted the TIR (83.32% vs. 66.80%, P < 0.05) and survival time of PEG-ACGs-Lipo. Conclusion An over-threshold dosing strategy proved to be a simple and feasible way to enhance the tumor delivery and antitumor efficacy of nanomedicines and was benefited to benefit their clinical result, especially for liposomal drugs. Graphical Abstract

Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory

“…In all literature, ,,, blank nanoparticles with a single particle size were used to verify the feasibility of the threshold theory. Therefore, this project intends to investigate whether changes in the size of BSA-NPs affect the in vivo distribution of LIBOD.…”

Robust Construction of Supersmall Zwitterionic Micelles Based on Hyperbranched Polycarbonates Mediates High Tumor Accumulation

“…The ex vivo imaging of tissues clearly showed that X-CBMs exhibited a remarkable accumulation in tumors (4.4- and 3.9-fold compared to CBMs and X-PEGMs, respectively) and low distribution in normal organs (Figure C,D), leading to a significantly higher tumor-to-normal tissue (T/N) ratio (Table S4). Moreover, it should be noted that X-PEGM was primarily accumulated in the liver and spleen in contrast to the tumors or other organs, indicating that the majority of X-PEGM was eliminated by the reticuloendothelial system (RES) accompanied by the liver/spleen toxicity for long-term use of PEG formulations. − …”

A simple but efficient tumor-targeted nanoparticle delivery system constructed by oleic acid

“…Hui Ao et al. ( 2022 ) fabricated Annona squamosa seed oil (ASSO) into nanoparticles using TPGS as a stabilizer. ASSO was mainly composed of OA and linoleic acid, together with a small amount of stearic acid and palmitic acid, of which unsaturated fatty acids account for about 70%.…”